Status: Available
A Compassionate Use (CU) Program of Odronextamab
Provide compassionate use of odronextamab
Trial details
Biological sex: AllType: Expanded AccessSponsor: Regeneron PharmaceuticalsUpdated: Oct 9, 2026
Eligibility criteria
Not listed